GS-441524 is an metabolite of the antiviral prodrug remdesivir, which has a short half-life of 24 hours.
Remdesivir and GS-441524 have both been tested and demonstrated to be clinically effective against feline coronavirus strains causing Feline Infectious Peritonitis (FIP). It is an virulent, lethal disease impacting cats mainly through compromised immune systems.
To fight off infectious viruses and generate immunity, cats need functional immune systems to produce white blood cells.
However, cats with FIP cannot generate the necessary white blood cells to combat the virus, which leads to either wet or dry FIP.
The recommended treatment is to take the medicine for 12 weeks. The dosage is based on the pet's weight and symptoms, as indicated below:
This medicine should be stored at room temperature or 2~4°C for better results. Avoid light and use within one year. Do not place in a sub-zero environment as this will result in the precipitation of active ingredients and the appearance of crystals, thus affecting the concentration and therapeutic effect.